Kirk Wojno

OncoCell MDx, an immunogenomics company developing noninvasive molecular diagnostic assays, has named Kirk Wojno as chief medical officer. Wojno is former head of urologic pathology at the University of Michigan; at Ascension Health System; and AmeriPath, a division of Quest Diagnostics. He has more than 30 years in medical practice and most recently served as the chief of pathology and laboratory services and director of cinical research for the Comprehensive Urology practice in Royal Oak, Michigan.